title: Molecular diagnostics for precision medicine in breast cancer treatment: what does the future hold?
authors.affiliation: Department of Medical Oncology, Fukushima Medical University, School of Medicine, 1 Hikarigaoka, Fukushima, Fukushima, 960-1295, Japan. ssaji@fmu.ac.jp.
authors.forename: Shigehira
authors.initials: S
authors.lastname: Saji
authors.affiliation: Department of Medical Oncology, Fukushima Medical University, School of Medicine, 1 Hikarigaoka, Fukushima, Fukushima, 960-1295, Japan.
authors.forename: Reiko
authors.initials: R
authors.lastname: Kimura-Tsuchiya
authors.affiliation: Department of Medical Oncology, Fukushima Medical University, School of Medicine, 1 Hikarigaoka, Fukushima, Fukushima, 960-1295, Japan.
authors.forename: Eisaku
authors.initials: E
authors.lastname: Sasaki
mesh_terms: D000631:Aminopyridines / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics / Q000378:metabolism; D002277:Carcinoma / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics / Q000378:metabolism; D051358:Cyclin-Dependent Kinase 4 / Q000235:genetics / Q000378:metabolism; D051361:Cyclin-Dependent Kinase 6 / Q000235:genetics / Q000378:metabolism; D004958:Estradiol / Q000031:analogs & derivatives / Q000627:therapeutic use; D000068338:Everolimus / Q000627:therapeutic use; D005260:Female; D000077267:Fulvestrant; D006801:Humans; D058990:Molecular Targeted Therapy; D057089:Pathology, Molecular; D010879:Piperazines / Q000627:therapeutic use; D057285:Precision Medicine; D011687:Purines / Q000627:therapeutic use; D011725:Pyridines / Q000627:therapeutic use; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000235:genetics / Q000378:metabolism; D011960:Receptors, Estrogen / Q000235:genetics / Q000378:metabolism; D058570:TOR Serine-Threonine Kinases / Q000235:genetics / Q000378:metabolism; D013629:Tamoxifen / Q000627:therapeutic use; D000068878:Trastuzumab / Q000627:therapeutic use
chemical_list: D000631:Aminopyridines; D000970:Antineoplastic Agents; D051358:Cyclin-Dependent Kinase 4; D051361:Cyclin-Dependent Kinase 6; D004958:Estradiol; D000068338:Everolimus; D000077267:Fulvestrant; D010879:Piperazines; D011687:Purines; D011725:Pyridines; D018719:Erb-b2 Receptor Tyrosine Kinases; D011960:Receptors, Estrogen; D058570:TOR Serine-Threonine Kinases; D013629:Tamoxifen; D000068878:Trastuzumab; C508053:ERBB2 protein, human; C500026:palbociclib; C000589651:ribociclib